| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Steinberg AD | |
| P2860 | cites work | A serum factor in lupus erythematosus with affinity for tissue nuclei | Q24672029 |
| Carcinoma of the Bladder complicating Cyclophosphamide Therapy | Q28340422 | ||
| Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis | Q30449890 | ||
| The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up | Q33554543 | ||
| Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus | Q34079980 | ||
| Cyclophosphamide in lupus nephritis: a controlled trial | Q34201904 | ||
| Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis | Q35571463 | ||
| Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction | Q36263544 | ||
| Reversal of nzb/nzw disease with total lymphoid irradiation | Q36342698 | ||
| Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis | Q36345944 | ||
| In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus | Q36359741 | ||
| Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus | Q39188695 | ||
| Letter: Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis | Q39354894 | ||
| Avidity of antibodies in SLE: relation to severity of renal involvement | Q39802398 | ||
| Cyclophosphamide: Use in Practice | Q39955269 | ||
| Renal syndromes associated with nonsteroidal antiinflammatory drugs | Q40168640 | ||
| Renal Effects of Prostaglandins and Clinical Adverse Effects of Nonsteroidal Anti-Inflammatory Agents | Q40175631 | ||
| Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and Cyclophosphamide | Q40691464 | ||
| Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus? | Q41028309 | ||
| Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions | Q41067146 | ||
| Effect of febrile plasma, typhoid vaccine and nitrogen mustard on renal manifestations of human glomerulonephritis. | Q41070834 | ||
| Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus | Q41364293 | ||
| Recognition of information in renal biopsies of patients with lupus nephritis | Q41458938 | ||
| Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus | Q41723885 | ||
| Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma | Q42240961 | ||
| Fatal Arrhythmia After Pulse Methylprednisolone Therapy | Q42574087 | ||
| Sudden death after methylprednisolone pulse therapy | Q42574954 | ||
| Seizure after pulse therapy with methyl prednisolone | Q42580628 | ||
| The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus | Q42823099 | ||
| The localization of in vivo bound complement in tissue section | Q42826669 | ||
| Progression of mesangial and focal to diffuse lupus nephritis | Q43460182 | ||
| Membranous lupus nephropathy: a clinicopathologic study | Q44436019 | ||
| A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis | Q44482867 | ||
| Cyclophosphamide and malignancy | Q45866144 | ||
| The clinical course of the proliferative and membranous forms of lupus nephritis. | Q47728168 | ||
| Immunologic factors and clinical activity in systemic lupus erythematosus | Q47817323 | ||
| Studies on the relation of pituitary-adrenal function to rheumatic disease. | Q51361914 | ||
| A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS | Q56417998 | ||
| Reversible “end-stage” lupus nephritis | Q57332328 | ||
| Amyloidosis and systemic lupus erythematosus | Q64361312 | ||
| Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients | Q66904183 | ||
| Immunologically-mediated acute renal failure of nonglomerular origin in the course of systemic lupus erythematosus [SLE]. Report of two cases | Q66919416 | ||
| Anaphylaxis after intravenous methylprednisolone administration | Q67258650 | ||
| Recurrent systemic lupus erythematosus involving renal allografts | Q67285736 | ||
| Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification | Q67370394 | ||
| Prognostic indices in lupus nephritis | Q67440483 | ||
| Lupus nephritis. Clinical course as related to morphologic forms and their transitions | Q67544571 | ||
| Renal vein thrombosis, nephrotic syndrome, and systemic lupus erythematosus: an association in four cases | Q67805779 | ||
| Hypertension and renal disease in systemic lupus erythematosus | Q67806367 | ||
| Qualitative characteristics of anti-DNA antibodies in lupus nephritis | Q68354916 | ||
| Cytotoxic drugs in treatment of nonmalignant diseases | Q68510689 | ||
| Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs | Q68859513 | ||
| Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis | Q69498786 | ||
| Incidence of infection in systemic lupus erythematosus | Q69733299 | ||
| Unusual transformations of renal involvement in systemic lupus erythematosus | Q69839326 | ||
| Treatment of intractable lupus nephritis with total lymphoid irradiation | Q69866067 | ||
| Lupus nephritis: varying complement-fixing properties of immunoglobulin G antibodies to antigens of cell nuclei | Q70091319 | ||
| Alternate-day steroid therapy in lupus nephritis | Q70132280 | ||
| Renal transplantation in systemic lupus erythematosus | Q70170389 | ||
| Focal proliferative lupus nephritis. A clinicopathologic study using the W.H.O. classification | Q70228965 | ||
| Chronic Hemodialysis in End-Stage Lupus Nephritis: Changes of Clinical and Serological Activities | Q70229667 | ||
| The Long-Term Clinical Course of Systemic Lupus Erythematosus in End-Stage Renal Disease | Q70237799 | ||
| Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis | Q70244450 | ||
| Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up | Q70261365 | ||
| Pathologic changes in the renal tubule in systemic lupus erythematosus | Q70338444 | ||
| Course of renal pathology in patients with systemic lupus erythematosus | Q70636100 | ||
| Survival rates of 2,728 patients with end-stage renal disease | Q70654131 | ||
| Studies of the pathogenesis of interstitial cystitis, obstructive uropathy, and intestinal malabsorption in a patient with systemic lupus erythematosus | Q70715050 | ||
| Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus | Q70749606 | ||
| Renal vein thrombosis: occurrence in membranous glomerulonephropathy and lupus nephritis | Q70775576 | ||
| Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy | Q70786737 | ||
| Cyclophosphamide therapy in murine lupus: effect of combining multiple subsets into a single randomized study | Q71061194 | ||
| Renal amyloidosis associated with systemic lupus erythematosus | Q71424275 | ||
| The clinical course of end-stage renal disease in systemic lupus erythematosus | Q71785533 | ||
| Relationship of renal histopathology in SLE nephritis to immunoglobulin class of anti-DNA | Q72072807 | ||
| Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance | Q72087634 | ||
| Randomised trial of plasma exchange in mild systemic lupus erythematosus | Q72541927 | ||
| Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein | Q74540895 | ||
| A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus | Q74795925 | ||
| Complement fixation with cell nuclei and DNA in lupus erythematosus | Q74795928 | ||
| Use of cortisone and adrenocorticotropic hormone in acute disseminated lupus erythematosus | Q75449680 | ||
| Simulation of the lupus erythematosus phenomenon by materials of fungal origin | Q75746652 | ||
| THE REPRODUCIBILITY OF SEMIQUANTITATIVE ANALYSES OF RENAL HISTOLOGY | Q78245776 | ||
| STEROID THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS BASED ON IMMUNOLOGIC CONSIDERATIONS | Q78310161 | ||
| Immunological studies in nephritis | Q78737004 | ||
| Azathioprine in the treatment of systemic lupus erythematosus. A controlled study | Q93709185 | ||
| The clinical usefulness of ACTH and cortisone | Q94407189 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 769-787 | |
| P577 | publication date | 1986-11-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | The treatment of lupus nephritis. | |
| P478 | volume | 30 |
| Q69938288 | Alternate-day prednisone therapy in children with IgA-associated nephritis |
| Q50603809 | An epidemiologic analysis of end-stage lupus nephritis. |
| Q37799087 | Azathioprine, cyclophosphamide and chlorambucil |
| Q35579156 | Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation |
| Q34309764 | Combination treatment in autoimmune diseases: systemic lupus erythematosus. |
| Q35009163 | Corticosteroid-induced hypersensitivity reactions |
| Q41226267 | Effect of long-term normalization of serum complement levels on the course of lupus nephritis |
| Q54571803 | Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis. |
| Q53161789 | Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis. |
| Q40868199 | End-stage renal disease in systemic lupus erythematosus |
| Q36013860 | Immunoglobulin E-mediated reactions to corticosteroids |
| Q40883177 | Immunosuppressive drug therapy in lupus nephritis |
| Q67789424 | Inhibition of Protein-Kinase C in Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect on Spontaneous Immunoglobulin Production |
| Q68125366 | Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL) |
| Q35665763 | Nephrotic syndrome in adults. A diagnostic and management challenge |
| Q39652272 | Overview of pediatric nephropathology |
| Q68918938 | Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity |
| Q40506580 | Systemic lupus erythematosus--disease management |
| Q39656638 | Systemic lupus erythematosus. Controversies in management |
| Q28332054 | The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy |
| Q36840264 | Treatment of systemic lupus erythematosus: which options do we have for therapy regimens? |
| Q73338674 | [Treatment of lupus nephritis in children] |
Search more.